Advertisement
Advertisement
U.S. markets open in 6 hours 55 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Acer Therapeutics Inc. (ACER)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.0200+0.0100 (+0.50%)
At close: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close2.0100
Open1.9800
Bid0.0000 x 3000
Ask0.0000 x 1200
Day's Range1.9593 - 2.1000
52 Week Range1.6800 - 5.3900
Volume65,370
Avg. Volume303,211
Market Cap28.907M
Beta (5Y Monthly)1.09
PE Ratio (TTM)N/A
EPS (TTM)-1.2440
Earnings DateFeb 28, 2022 - Mar 04, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ACER

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Acer Therapeutics Inc.
    Daily – Vickers Top Buyers & Sellers for 12/07/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    yesterdayArgus Research
View more
  • Benzinga

    5 Stocks To Watch For November 22, 2021

    Some of the stocks that may grab investor focus today are: Wall Street expects Agilent Technologies, Inc. (NYSE: A) to report quarterly earnings at $1.03 per share on revenue of $1.45 billion before the opening bell. Agilent shares rose 0.4% to $164.90 in after-hours trading. NIO Inc. (NYSE: NIO) shares dropped more than 9% in the week ending Nov. 19, underperforming most of its electric-vehicle peers. The stock, however, saw an upward bounce in late trading on Friday as the company announced Fr

  • GlobeNewswire

    Acer Therapeutics Reports Q3 2021 Financial Results and Provides Corporate Update

    NEWTON, Mass., Nov. 19, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today reported financial results for the third quarter ended September 30, 2021 and provided an update on Acer’s recent corporate developments. “This quarter was all about preparing regulatory filings to advance our pipeline pr

  • GlobeNewswire

    Acer Therapeutics and Relief Therapeutics Announce Issuance of U.S. Patent 11,154,521 Covering ACER-001 Formulation

    Key ACER-001 formulation composition of matter patent strengthens proprietary position in U.S. until 2036NEWTON, Mass. and GENEVA, Switzerland, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER) (“Acer”) and its collaboration partner, RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF) (“Relief”), today announced that the U.S. Patent and Trademark Office (USPTO) has issued a new U.S. patent to Acer for certain claims related to ACER-001 (sodium phenylbutyrate). Patent 11

Advertisement
Advertisement